TARO logo

TARO Operating Expenses

Annual Operating Expenses

$283.47 M
+$32.86 M+13.11%

March 31, 2024

Summary

Performance

1-Year Change

+13.11%

3-Year Change

+87.1%

5-Year Change

+85.02%

15-Year Change

+81.36%

TARO Operating Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$283.47 M
TARO annual total operating expenses is currently at an all-time high

3-Year Low

$151.51 M
TARO annual total operating expenses is currently +87.10% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Mar 31, 2024
TARO previous annual earnings announcement was published on Mar 31, 2024

Next Annual Earnings Report Date

N/A
TARO next annual earnings announcement has not yet been scheduled

OtherTAROexpensesmetrics:

Annual Total Expenses

$607.70 M
TARO annual total expenses is $607.70 million

Annual Interest Expense

-
TARO annual interest expense value is unknown

Annual Income Tax

$28.80 M
TARO annual income tax is $28.80 million

Annual Cost Of Goods Sold

$324.23 M
TARO annual cost of goods sold is $324.23 million

Quarterly Operating Expenses

$78.61 M
+$14.61 M+22.82%

March 31, 2024

Summary

Performance

3-Month Change

+22.82%

1-Year Change

+22.82%

3-Year Change

+102.48%

5-Year Change

+118.78%

TARO Quarterly Operating Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$78.61 M
TARO quarterly total operating expenses is currently at an all-time high

3-Year Low

$39.04 M
TARO quarterly total operating expenses is currently +101.33% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Mar 31, 2024
TARO previous earnings announcement was published on Mar 31, 2024

Next Quarterly Earnings Report Date

N/A
TARO next earnings announcement has not yet been scheduled

OtherTAROexpensesmetrics:

Quarterly Total Expenses

$156.16 M
TARO quarterly total expenses is $156.16 million

Quarterly Interest Expense

-
TARO quarterly interest expense value is unknown

Quarterly Income Tax

$11.15 M
TARO quarterly income tax is $11.15 million

Quarterly Cost Of Goods Sold

$77.55 M
TARO quarterly cost of goods sold is $77.55 million

Operating Expenses Formula

Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses

Annual Operating Expenses

$283.47 M
TARO annual total operating expenses is $283.47 million

Annual SGA

$218.94 M
TARO annual SGA is $218.94 million

Annual D&A

$31.09 M
TARO annual depreciation & amortization is $31.09 million

TARO Operating Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+13.1%+22.8%
3 y3 years+87.1%+102.5%
5 y5 years+85.0%+118.8%

TARO Operating Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high-46.6%at high-50.3%
5 y5-yearat high-46.6%at high-55.2%
alltimeall timeat high-98.8%at high-98.2%

Taro Pharmaceutical Industries Operating Expenses History

DateAnnualQuarterly
Mar 2024
$283.47 M(+13.1%)
$78.61 M(+22.8%)
Dec 2023
-
$64.00 M(-7.1%)
Sep 2023
-
$68.86 M(-4.4%)
Jun 2023
-
$72.01 M(+8.4%)
Mar 2023
$250.61 M(+49.0%)
$66.43 M(+5.8%)
Dec 2022
-
$62.77 M(+16.7%)
Sep 2022
-
$53.78 M(-20.5%)
Jun 2022
-
$67.63 M(+20.6%)
Mar 2022
$168.22 M(+11.0%)
$56.07 M(+43.6%)
Dec 2021
-
$39.04 M(+7.9%)
Sep 2021
-
$36.18 M(-2.0%)
Jun 2021
-
$36.93 M(-4.9%)
Mar 2021
$151.51 M(-1.1%)
$38.82 M(+5.3%)
Dec 2020
-
$36.88 M(-9.2%)
Sep 2020
-
$40.63 M(+15.5%)
Jun 2020
-
$35.18 M(-21.9%)
Mar 2020
$153.19 M(-0.0%)
$45.06 M(+25.4%)
Dec 2019
-
$35.93 M(-8.0%)
Sep 2019
-
$39.04 M(+17.7%)
Jun 2019
-
$33.16 M(-30.7%)
Mar 2019
$153.21 M(-3.4%)
$47.83 M(+23.9%)
Dec 2018
-
$38.61 M(+29.4%)
Sep 2018
-
$29.84 M(-19.2%)
Jun 2018
-
$36.93 M(-16.2%)
Mar 2018
$158.61 M(+1.5%)
$44.08 M(+12.2%)
Dec 2017
-
$39.29 M(+8.1%)
Sep 2017
-
$36.34 M(-6.6%)
Jun 2017
-
$38.91 M(-7.5%)
Mar 2017
$156.30 M(-4.4%)
$42.08 M(+9.8%)
Dec 2016
-
$38.31 M(+7.2%)
Sep 2016
-
$35.73 M(-11.1%)
Jun 2016
-
$40.17 M(-5.5%)
Mar 2016
$163.53 M(+6.8%)
$42.51 M(+4.2%)
Dec 2015
-
$40.81 M(-4.6%)
Sep 2015
-
$42.77 M(+14.3%)
Jun 2015
-
$37.43 M(-18.8%)
Mar 2015
$153.15 M(+4.1%)
$46.09 M(+34.9%)
Dec 2014
-
$34.17 M(-3.8%)
Sep 2014
-
$35.51 M(-5.0%)
Jun 2014
-
$37.37 M(-6.1%)
Mar 2014
$147.16 M(+10.7%)
$39.81 M(+7.5%)
Dec 2013
-
$37.03 M(-0.3%)
Sep 2013
-
$37.16 M(+12.0%)
Jun 2013
-
$33.16 M(-3.4%)
Mar 2013
$132.95 M(+303.5%)
$34.33 M(+5.3%)
Dec 2012
-
$32.59 M(+5.4%)
Sep 2012
-
$30.92 M(-2.8%)
Jun 2012
-
$31.81 M(-3.5%)
Mar 2012
$32.95 M(-73.6%)
$32.95 M(+7.0%)
Dec 2011
$124.78 M(-13.5%)
$30.80 M(-1.8%)
Sep 2011
-
$31.37 M(-4.6%)
Jun 2011
-
$32.90 M(+10.7%)
Mar 2011
-
$29.72 M(-19.7%)
Dec 2010
$144.29 M(+8.0%)
$37.02 M(-0.6%)
Sep 2010
-
$37.24 M(+2.6%)
Jun 2010
-
$36.30 M(+7.6%)
Mar 2010
-
$33.73 M(+13.2%)
Dec 2009
$133.65 M
$29.81 M(-12.5%)
Sep 2009
-
$34.06 M(-8.6%)
Jun 2009
-
$37.26 M(+14.6%)
DateAnnualQuarterly
Mar 2009
-
$32.52 M(-14.9%)
Dec 2008
$134.07 M(+5.5%)
$38.20 M(+13.6%)
Sep 2008
-
$33.62 M(+2.3%)
Jun 2008
-
$32.86 M(-35.7%)
Dec 2007
$127.09 M(-12.5%)
-
Dec 2006
$145.32 M(-7.1%)
-
Dec 2005
$156.46 M(-5.3%)
$51.14 M(+50.5%)
Sep 2005
-
$33.98 M(-3.4%)
Jun 2005
-
$35.17 M(-2.8%)
Mar 2005
-
$36.17 M(-5.2%)
Dec 2004
$165.24 M(+19.5%)
$38.16 M(-4.9%)
Sep 2004
-
$40.13 M(-2.3%)
Jun 2004
-
$41.09 M(-10.4%)
Mar 2004
-
$45.87 M(+6.3%)
Dec 2003
$138.32 M(+75.4%)
$43.16 M(+17.0%)
Sep 2003
-
$36.90 M(+15.3%)
Jun 2003
-
$32.00 M(+21.8%)
Mar 2003
-
$26.26 M(+14.1%)
Dec 2002
$78.85 M(+27.8%)
$23.02 M(+16.0%)
Sep 2002
-
$19.85 M(+5.1%)
Jun 2002
-
$18.89 M(+10.5%)
Mar 2002
-
$17.10 M(+4.5%)
Dec 2001
$61.72 M(+32.7%)
$16.36 M(+1.0%)
Sep 2001
-
$16.20 M(-0.8%)
Jun 2001
-
$16.33 M(+27.3%)
Mar 2001
-
$12.83 M(-0.1%)
Dec 2000
$46.49 M(+10.5%)
$12.85 M(+6.8%)
Sep 2000
-
$12.02 M(+6.0%)
Jun 2000
-
$11.34 M(+10.2%)
Mar 2000
-
$10.29 M(-32.6%)
Dec 1999
$42.07 M(+23.7%)
$15.27 M(+67.8%)
Sep 1999
-
$9.10 M(-3.2%)
Jun 1999
-
$9.40 M(+11.9%)
Mar 1999
-
$8.40 M(+21.7%)
Dec 1998
$34.00 M(+9.7%)
-
Mar 1998
-
$6.90 M(-36.7%)
Dec 1997
$31.00 M(+6.9%)
$10.90 M(+58.0%)
Sep 1997
-
$6.90 M(+3.0%)
Jun 1997
-
$6.70 M(+6.3%)
Mar 1997
-
$6.30 M(-33.0%)
Dec 1996
$29.00 M(+15.1%)
$9.40 M(+42.4%)
Sep 1996
-
$6.60 M(-4.3%)
Jun 1996
-
$6.90 M(+9.5%)
Mar 1996
-
$6.30 M(+43.2%)
Dec 1995
$25.20 M(+30.6%)
-
Dec 1994
$19.30 M(+32.2%)
-
Dec 1993
$14.60 M(+17.7%)
-
Dec 1992
$12.40 M(+51.2%)
$4.40 M(+57.1%)
Sep 1992
-
$2.80 M(-3.4%)
Jun 1992
-
$2.90 M(+31.8%)
Mar 1992
-
$2.20 M(-4.3%)
Dec 1991
$8.20 M(+49.1%)
$2.30 M(+15.0%)
Sep 1991
-
$2.00 M(0.0%)
Jun 1991
-
$2.00 M(+5.3%)
Mar 1991
-
$1.90 M(+35.7%)
Dec 1990
$5.50 M(+3.8%)
-
Mar 1990
-
$1.40 M
Dec 1989
$5.30 M(+39.5%)
-
Dec 1988
$3.80 M(+8.6%)
-
Dec 1987
$3.50 M
-

FAQ

  • What is Taro Pharmaceutical Industries annual total operating expenses?
  • What is the all time high annual operating expenses for Taro Pharmaceutical Industries?
  • What is Taro Pharmaceutical Industries annual operating expenses year-on-year change?
  • What is Taro Pharmaceutical Industries quarterly total operating expenses?
  • What is the all time high quarterly operating expenses for Taro Pharmaceutical Industries?
  • What is Taro Pharmaceutical Industries quarterly operating expenses year-on-year change?

What is Taro Pharmaceutical Industries annual total operating expenses?

The current annual operating expenses of TARO is $283.47 M

What is the all time high annual operating expenses for Taro Pharmaceutical Industries?

Taro Pharmaceutical Industries all-time high annual total operating expenses is $283.47 M

What is Taro Pharmaceutical Industries annual operating expenses year-on-year change?

Over the past year, TARO annual total operating expenses has changed by +$32.86 M (+13.11%)

What is Taro Pharmaceutical Industries quarterly total operating expenses?

The current quarterly operating expenses of TARO is $78.61 M

What is the all time high quarterly operating expenses for Taro Pharmaceutical Industries?

Taro Pharmaceutical Industries all-time high quarterly total operating expenses is $78.61 M

What is Taro Pharmaceutical Industries quarterly operating expenses year-on-year change?

Over the past year, TARO quarterly total operating expenses has changed by +$14.61 M (+22.82%)